CN Stock MarketDetailed Quotes

Gansu Longshenrongfa Pharmaceutical Industry (300534)

Watchlist
  • 8.54
  • +0.12+1.43%
Market Closed May 22 15:00 CST
2.59BMarket Cap52.39P/E (TTM)

Gansu Longshenrongfa Pharmaceutical Industry (300534) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
合剂类599.72M67.62%
Drop pills200.85M22.65%
Medical devices and others52.14M5.88%
Material sales11.58M1.31%
house lease7.94M0.90%
Capsule type4.91M0.55%
Tablets3.91M0.44%
Inspection and detection2.2M0.25%
Other2.16M0.24%
Service fee income1.55M0.18%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Drug sales810.16M91.34%
Medical devices and others52.14M5.88%
Material sales11.58M1.31%
house lease7.94M0.90%
Inspection and detection2.2M0.25%
Service fee income1.55M0.18%
Technical services761.76K0.09%
提供咨询617.4K0.07%
View all

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic sales874.83M98.63%
Foreign sales12.13M1.37%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More